Development of evidence-based Australian medication-related indicators of potentially preventable hospitalisations: A modified RAND appropriateness method

BMJ Open

Volumn 4, Issue 4, 2014, Pages

  Caughey, Gillian E ^a   Kalisch Ellett, Lisa M ^a   Wong, Te Ying ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CONFUSION; ACUTE CORONARY SYNDROME; ADVERSE OUTCOME; ARTICLE; AUSTRALIA; BIPOLAR DISORDER; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CLINICAL INDICATOR; CONTENT VALIDITY; CONTROLLED STUDY; DIABETES MELLITUS; EVIDENCE BASED PRACTICE; FRACTURE; GASTROINTESTINAL DISEASE; GENERAL PRACTITIONER; HEART ARRHYTHMIA; HEART BLOCK; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERCALCEMIA; HYPERGLYCEMIA; HYPOGLYCEMIA; KIDNEY FAILURE; MEDICAL SPECIALIST; MEDICATION THERAPY MANAGEMENT; MENTAL HEALTH; MODIFIED RAND APPROPRIATENESS METHOD; OSTEOPOROSIS; OUTCOME ASSESSMENT; PHARMACIST; PRIMARY HEALTH CARE; URINE RETENTION; VENOUS THROMBOEMBOLISM; ADVERSE DRUG REACTION; EVIDENCE BASED MEDICINE; STATISTICS AND NUMERICAL DATA;

AUSTRALIA; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EVIDENCE-BASED MEDICINE; HOSPITALIZATION; HUMANS; PRIMARY HEALTH CARE;

EID: 84899498081     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004625     Document Type: Article

References (71)

1. Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care 2003;15:523-30. (Pubitemid 37540789)
2. Robertson H, MacKinnon N. Development of a list of consensus-approved clinical indicators of preventable drug-related morbidity in older adults. Clin Ther 2002;24:1595-613. (Pubitemid 35351845)
3. Bindman A, Grubmach K, Osmond D, et al. Preventable hospitalizations and access to health care. JAMA 1995;274:305-11.
4. Roughead E, Semple S. Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002-2008. Aust N Z Health Policy 2009;6:18.
5. Howard R, Avery A, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007;63:136-47. (Pubitemid 46072098)
6. MacKinnon N, Hepler C. Preventable drug-related morbidity in older adults. 1. Indicator development. J Manag Care Pharm 2002;8:365-71.
7. Sauer B, Hepler C, Cherney B, et al. Computerized indicators of potential drug-related emergency department and hospital admissions. Am J Manag Care 2007;13:29-35. (Pubitemid 46180508)
8. Morris CJ, Cantrill JA, Hepler CD, et al. Preventing drug-related morbidity - determining valid indicators. Int J Qual Health Care 2002;14:183-98. (Pubitemid 34679132)
9. Mackinnon NJ, Hepler CD. Indicators of preventable drug-related morbidity in older adults 2. Use within a managed care organization. J Manag Care Pharm 2003;9:134-41.
10. MacKinnon NJ, Hartnell NR, Bowles SK, et al. Incident-event rate of preventable drug-related morbidity in older Adultsin Nova Scotia. Can J Geriatr 2006;9:159-63. (Pubitemid 46225152)
11. Kalisch LM, Caughey GE, Barratt JD, et al. Prevalence of preventable medication-related hospitalizations in Australia: an opportunity to reduce harm. Int J Qual Health Care 2012;24:239-49.
12. Morris C, Cantrill J. Preventing drug-related morbidity - the development of quality indicators. J Clin Pharm Ther 2003;28:295-305. (Pubitemid 37041138)
13. Morris C, Cantrill J. Preventable drug-related morbidity indicators in the US and UK. J Manag Care Pharm 2002;8:372-7.
14. Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs 2000;32:1008-15.
15. Keeney S, Hasson F, McKenna H. A critical review of the Delphi technique as a research methodology for nursing. Int J Nurs Stud 2001;38:195-200. (Pubitemid 33660489)
16. Runciman WB, Hunt TD, Hannaford NA, et al. CareTrack: assessing the appropriateness of health care delivery in Australia. Med J Aust 2012;197:100-5.
17. Avery A, Dex G, Mulvaney C, et al. Development of prescribing-safety indicators for GPs using the RAND appropriateness method. Br J Gen Pract 2011;61:e526-e36.
18. Hunt T, Ramanathan S, Hannaford N, et al. CareTrack Australia: assessing the appropriateness of adult healthcare: protocol for a retrospective medical record review. BMJ Open 2012;2:e000665.
19. Teresato AG, Lougheed MD, Gershon AS, et al. Evidence-based performance indicators of primary care for asthma: a modified RAND appropriateness method. Int J Qual Health Care 2010;22:476-85.
20. Australian Government Australian Institute of Health and Welfare (AIHW). Australian Institute of Health and Welfare: National Health Priority Areas. http://www.aihw.gov.au/national-health-priority-areas/(accessed 17 Mar 2014).
21. Boyce PM, Talley NJ, Burke C, et al. Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study. Intern Med J 2006;36:28-36. (Pubitemid 43362544)
22. Australian Government National Health and Medical Research Council. NHMRC levels of evidence and grades for recommendations for developers of guidelines 2009. https://www.nhmrc.gov.au/-files-nhmrc/file/guidelines/developers/nhmrc- levels-grades-evidence-120423.pdf (accessed 17 Mar 2014).
23. Australian Government Department of Health and Ageing. Schedule of pharmaceutical benefits. http://www.pbs.gov.au/browse/publications (accessed 17 Mar 2014).
24. Therapeutic Guidelines Limited. Therapeutic guidelines. http://www.tg.org.au/ (accessed 25 Jul 2012).
25. Rossi S. ed Australian medicines handbook. Adelaide: AMH, 2011.
26. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (Chronic Heart Failure Guidelines Expert Writing Panel). Guidelines for the prevention, detection and management of chronic heart failure in Australia. Updated October 2011. http://www.heartfoundation.org.au/ SiteCollectionDocuments/Chronic-Heart-Failure-Guidelines-2011.pdf (accessed 17 Mar 2014).
27. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand. Reducing risk in heart disease 2007 (updated 2008): Guidelines for preventing cardiovascular events in people with coronary heart disease. http://www.heartfoundation.org.au/SiteCollectionDocuments/Reduce-risk-in-heart- disease-guideline. pdf (accessed 17 Mar 2014).
28. Acute Coronary Syndrome Guidelines Working Group. Guidelines for the management of acute coronary syndromes 2006. Med J Aust 2006;184(8 Suppl):S1-S32.
29. National Heart Foundation (National Blood Pressure Advisory Committee). Hypertension management guide for Doctors National Heart Foundation, 2004.
30. National Stroke Foundation. Clinical guidelines for stroke management 2010. Melbourne, Australia. http://strokefoundation. com.au/site/media/clinical- guidelines-stroke-managment-2010-interactive.pdf (accessed 17 Mar 2014).
31. McKenzie DK, Abramson M, Crockett AJ, et al. The COPD-X Plan: Australian and New Zealand Guidelines for the management of chronic obstructive pulmonary disease V2.30. 2011. http://www.copdx.org.au/home (accessed 17 Mar 2014).
32. National Asthma Council Australia. Asthma management handbook 2006. Melbourne, Australia: National Asthma Council Australia, 2006.
33. Diabetes Australia, Royal Australian College for General Practitioners. Diabetes management in general practice. Guidelines for type 2 diabetes. 16th edn. Diabetes Australia, 2010.
34. Colagiuri S, Dickinson S, Girgis S, et al. National evidence based guideline for blood glucose control in type 2 diabetes. Canberra, Australia: Diabetes Australia and the NHMRC, 2009.
35. Royal Australian College of General Practitioners. Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men. 2010. http://www.racgp.org.au/download/documents/Guidelines/ Musculoskeletal/racgp-osteo-guideline.pdf (accessed 17 Mar 2014).
36. The Royal Australian College of General Practitioners. Guideline for the non-surgical management of hip and knee osteoarthritis, South Melbourne, Victoria: RACGP, 2009. https://www.nhmrc.gov.au/-files-nhmrc/publications/ attachments/cp117-hip-knee-osteoarthritis. pdf (accessed 17 Mar 2014).
37. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Depression. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aus N Z J Psychiatry 2004;38:389-407.
38. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder. Aust N Z J Psychiatry 2004;38:280-305.
39. Australian Governement: National Health and Medical Research Council (NHMRC). NHMRC additional levels of evidence and grades for recommendations for developers of guidelines. http://www.nhmrc.gov.au/-files-nhmrc/file/guidelines/ levels-grades05.pdf (accessed 17 Mar 2014).
40. World Health Organization International Classification of Diseases. International statistical classification of diseases and related health problems 10th revision, 2007. http://www.who.int/classifications/apps/icd/icd10online/ (accessed 8 Aug 2009).
41. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
42. Hepler C, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43. (Pubitemid 20138134)
43. Australian Institute of Health and Welfare (AIHW). Australian hospital statistics 2010-11. Health services series no 50. Cat. no. HSE 134. Canberra: Australian Government AIHW, 2012. http://www.aihw.gov.au/publication-detail/?id= 10737421633 (accessed 17 Mar 2014).
44. Fitch K, Bernstein S, Aguilar M, et al. The RAND/UCLA appropriateness method user's manual. Santa Monica: RAND, 2001.
45. McGlynn E, Asch S, Adams J, et al. The quality of health care delivered to adults in the United States. New Engl J Med 2003;348:2635-45. (Pubitemid 36741592)
46. Bonevski B, Magin P, Horton G, et al. Response rates in GP surveys. Trialling two recruitment strategies. Aust Fam Phys 2011;40:427-30.
47. Britt H, Miller G, Charles J, et al. General practice activity in Australia 2008-09. BEACH: bettering the evaluation and care of health. General Practice Series No. 25. Cat No. GEP 25. Canberra: AIHW, 2009.
48. Johnson C, Lizama N, Garg N, et al. Australian general practitioners' preferences for managing the care of people diagnosed with cancer. Asia Pac J Clin Oncol 2012; doi: 10.1111/ajco.12047
49. Scott PA, Kingsley GH, Scott DL. Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials. Eur J Heart Fail 2008;10:1102-7.
50. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007;356:2457-71. (Pubitemid 46919772)
51. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-235.
52. Mosca L, Grady D, Barrett-Connor E, et al. Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease. Stroke 2009;40:147-55.
53. Han L, McCusker J, Cole M, et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001;161:1099-105. (Pubitemid 32685536)
54. Edwards JG, Anderson I. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs 1999;57:507-33. (Pubitemid 29196919)
55. Centre for Allied Health Evidence; NHMRC, Department of Health and Ageing. Systematic literature review on the detection, diagnosis, management and prevention of glaucoma. Canberra, Australia: Australian Government, National Health and Medical Research Council, 2009.
56. Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518-27.
57. Australian Government. Department of Health and Ageing. NHMRC. The Australian immunisation handbook. 9th edn. Canberra, Australia: Commonwealth of Australia, 2009.
58. Griffin MR, Zhu Y, Moore MR, et al. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. New Engl J Med 2013;369:155-63.
59. Macintyre PE, Scott DA, Visser EJ, et al. Working group of the Australian and, New Zealand College of Anaesthetists and Faculty of Pain Medicine. Acute pain management: scientific evidence. 3rd edn. Melbourne: ANZCA & FPM, 2010.
60. Herbison P, Hay-Smith J, Ellis G, et al. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 2003;326:841.
61. McNicol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003;4:231-56. (Pubitemid 36807905)
62. Wang WH, Huang JQ, Zheng GF, et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 2007;5:178-85. (Pubitemid 46216930)
63. Moayyedi P, Deeks J, Talley NJ, et al. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 2003;98:2621-6. (Pubitemid 38020099)
64. Laine L, Smith R, Min K, et al. Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2006;24:751-67.
65. Lloyd Jones M, Wilkinson A. Adverse effects and persistence with therapy in patients taking oral alendronate, etidronate or risedronate: a systematic review. The National Institute for Clinical Excellence, 2006.
66. Kanis JA, Johansson H, Oden A, et al. A Meta-analysis of prior corticosteroid use and fracture risk. J Bone Mineral Res 2004;19:893-9. (Pubitemid 41103445)
67. Hartikainen S, Lönnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol Series A Biol Sci Med Sci 2007;62:1172-81. (Pubitemid 47599431)
68. Gheorghiade M, van Veldhuisen DJ, et al. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation 2006;113:2556-64. (Pubitemid 43948035)
69. Kallas M, Green F, Hewison M, et al. Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metabol 2010;95:3111-17.
70. Chadban S HM, Twigg S, Thomas M, et al. National evidence based guideline for diagnosis, prevention and management of chronic kidney disease in type 2 diabetes. Canberra, Australia. http://diabetesaustralia.com.au/PageFiles/763/ Chronic%20Kidney%20Disease%20Guideline%20August%202009.pdf (accessed 17 Mar 2014).
71. Diabetes Australia Guideline Development Consortium; Australian Centre for Diabetes Strategies. National evidence based guidelines for the management of type 2 diabetes mellitus. Part 7 lipid control in type 2 diabetes. Australian Centre for Diabetes Strategies. http://www.nhmrc.gov.au/publications/synopses/ di7todi13syn.htm (accessed 17 Mar 2014).